Генетическое типирование при болезнях ионных каналов в профилактике внезапной сердечной смерти

Автор: Качнов В.А., Тыренко В.В., Колюбаева С.Н., Бологов С.Г., Кольцов А.В., Синопальников Д.О., Рудченко И.В.

Журнал: Вестник Национального медико-хирургического центра им. Н.И. Пирогова @vestnik-pirogov-center

Рубрика: Обзоры литературы

Статья в выпуске: 1 т.13, 2018 года.

Бесплатный доступ

Короткий адрес: https://sciup.org/140225833

IDR: 140225833

Список литературы Генетическое типирование при болезнях ионных каналов в профилактике внезапной сердечной смерти

  • Nichol, G., Rumsfeld, J., Eigel, B., Abell,a B.S., Labarthe, D., Hong, Y. et al. Essential features of designating out-of-hospital cardiac arrest as a reportable event: A scientific statement from the American Heart Association Emergency Cardiovascular Care Committee; Council on Cardiopulmonary, Perioperative, And Critical Care; Council on Cardiovascular Nursing; Council on Clinical Cardiology; and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2008 (117): 2299-2308 DOI: 10.1161/CIRCULATIONAHA.107.189472
  • Chugh, S.S., Senashova, O., Watts, A., Tran, P.T., Zhou, Z., Gong, Q. et al. Postmortem molecular screening in unexplained sudden death. J. Am. Coll. Cardiol. 2004(43): 1625-1629 DOI: 10.1016/j.jacc.2003.11.052
  • De Vreede-Swagemakers, J.J., Gorgels, A.P., Dubois-Arbouw, W.I., van Ree, J.W., Daemen, M.J., Houben, L.G. et al. Out-of-hospital cardiac arrest in the 1990’s: A population-based study in the maastricht area on incidence, characteristics and survival. J. Am. Coll. Cardiol. 1997(30): 1500-1505.
  • Byrne, R., Constant, O., Smyth, Y., Callagy, G., Nash, P., Daly, K. et al. Multiple source surveillance incidence and aetiology of out-of-hospital sudden cardiac death in a rural population in the West of Ireland. Eur. Heart J. 2008(29): 1418-1423 DOI: 10.1093/eurheartj/ehn155
  • Hua, W., Zhang, L.F., Wu, Y.F., Liu, X.Q., Guo, D.S., Zhou, H.L. et al. Incidence of sudden cardiac death in China: Analysis of 4 regional populations. J. Am. Coll. Cardiol. 2009(54): 1110-1118 DOI: 10.1016/j.jacc.2009.06.016
  • Eckart, R.E., Shry, E.A., Burke, A.P., McNear, J.A., Appel, D.A., Castillo-Rojas, L.M. et al. Sudden death in young adults: An autopsy-based series of a population undergoing active surveillance. J. Am. Coll. Cardiol. 2011(58): 1254-1261 DOI: 10.1016/j.jacc.2011.01.049
  • Fishman, G.I., Chugh, S.S., Dimarco. J,P., Albert, C.M., Anderson, M.E., Bonow, R.O. et al. Sudden cardiac death prediction and prevention: Report from a National Heart, Lung, And Blood Institute And Heart Rhythm Society Workshop. Circulation 2010(122): 2335-2348 DOI: 10.1161/CIRCULATIONAHA.110.976092
  • Shljahto, E.V., Arutjunov, G.P., Belenkov, Ju.N., Ardashev, A.V. National guidelines for risk assessment and prevention of sudden cardiac death. Archive of internal medicine. 2013(4): 5-15 DOI: 10.20514/2226-6704-2013-0-4-5-15
  • Priori, S.G., Blomström-Lundqvist, С., Mazzanti, A., Bloma, N., Borggrefe, M., Camm, J. ESC recommendations on treatment of patients with ventricular arrhythmias and prevention of sudden cardiac death 2015. Russian Cardiology Journal 2016,7(135): 5-86 DOI: 10.15829/1560-4071-2016-7-5-86
  • Deo, R., Norby, F.L., Katz, R, Sotoodehnia, N., Adabag, S., DeFilippi, C.R. et al. Development and Validation of a Sudden Cardiac Death Prediction Model for the General Population. Circulation. 2016 Sep 13; 134(11): 806-16 DOI: 10.1161/CIRCULATIONAHA.116.023042
  • Shinozaki, K., Nonogi, H., Nagao, K., Becker, L.B. Strategies to improve cardiac arrest survival: a time to act. Acute Medicine & Surgery 2016(3): 61-64 DOI: 10.1002/ams2.192
  • Willich, S.N., Levy, D., Rocco, M.B., Tofler, G.H., Stone, P.H., Muller, J.E. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol. 1987(60): 801-806. ) 91027-7 DOI: 10.1016/0002-9149(87
  • Englund, A., Behrens. S., Wegscheider, K., Rowland, E. Circadian variation of malignant ventricular arrhythmias in patients with ischemic and nonischemic heart disease after cardioverter defibrillator implantation. European 7219 Jewel Investigators. J Am Coll Cardiol. 1999(34): 1560-1568 DOI: 10.1016/S0735-1097(99)00369-1
  • Peters, R.W., McQuillan, S., Gold, M.R. Interaction of septadian and circadian rhythms in life-threatening ventricular arrhythmias in patients with implantable cardioverter-defibrillators. Am J Cardiol. 1999(84): 555-557. DOI: 10.1016/S00-02-9149(99)00376-8.
  • The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989(129): 687-702.
  • Fried, L.P., Borhani, N.O., Enright, P., Furberg, C.D., Gardin, J.M., Kronmal, R.A. et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991(1): 263-276 DOI: 10.1016/1047-2797(91)90005-W
  • Myerburg, R.J., Junttila, M.J. Sudden cardiac death caused by coronary heart disease. Circulation 2012(125): 1043-1052 DOI: 10.1161/CIRCULATIONAHA.111.023846
  • Arzamendi, D., Benito, B., Tizon-Marcos H., Flores, J., Tanguay, J.F., Ly, H. et al. Increase in sudden death from coronary artery disease in young adults. Am. Heart J. 2011(161): 574-580 DOI: 10.1016/j.ahj.2010.10.040
  • Boczek, N.J., Tester, D.J., Ackerman, M.J. The molecular autopsy: An indispensable step following sudden cardiac death in the young? Herzschrittmacherther. Elektrophysiol. 2012(23): 167-173 DOI: 10.1007/s00399-012-0222-x
  • Campuzano, O., Allegue, C., Partemi, S., Iglesias, A., Oliva, A., Brugada, R. Negative autopsy and sudden cardiac death. Int. J. Leg. Med. 2014(128): 599-606 DOI: 10.1007/s00414-014-0966-4
  • Jervell, A., Lange-Nielsen, F. Congenital deaf-mutism, functional heart disease with prolongation of the QT interval and sudden death. Am. Heart J. 1957(54): 59-68. PMID: 13435203.
  • Levine, S.A., Woodworth, C.R. Congenital deaf-mutism, prolonged qt interval, syncopal attacks and sudden death. N. Engl. J. Med. 1958(259): 412-417 DOI: 10.1056/NEJM195808282590902
  • Romano, C., Gemme, G., Pongiglione, R. Rare cardiac arrythmias of the pediatric age. II. Syncopal attacks due to paroxysmal ventricular fibrillation. (presentation of 1st case in Italian pediatric literature). Clin. Pediatr. 1963(45): 656-683. PMID: 14158288.
  • Ward, O.C. A new familial cardiac syndrome in children. J. Ir. Med. Assoc. 1964 (54):103-106. PMID: 14136838.
  • Schwartz, P.J., Moss, A.J., Vincent, G.M., Crampton, R.S. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993(88): 782-784 DOI: 10.1161/01.CIR.88.2.782
  • Kaufman, E.S. Arrhythmic risk in congenital long QT syndrome. J. Electrocardiol. 2011(44): 645-649 DOI: 10.1016/jjelectrocard.2011.07.023
  • Keating, M., Atkinson, D., Dunn, C., Timothy, K., Vincent, G.M, Leppert, M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the harvey RAS-1 gene. Science 1991(252): 704-706 DOI: 10.1126/science.1673802
  • Kapplinger, J.D., Tester, D.J., Salisbury, B.A., Carr, J.L., Harris-Kerr C, Pollevick GD et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the familion long QT syndrome genetic test. Heart Rhythm 2009(6): 1297-1303 DOI: 10.1016/j.hrthm.2009.05.021
  • Fernândez-Falgueras, A., Sarquella-Brugada, G., Brugada, J., Brugada R and Campuzano, O. Cardiac Channelopathies and Sudden Death: Recent Clinical and Genetic Advances. Biology 2017, 6(1), 7 DOI: 10.3390/biology6010007
  • Bellocq, C., van Ginneken, A.C., Bezzina, C.R., Alders, M., Escande, D., Mannens, M.M., Baro, I. et al. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 2004(109): 2394-2397. 0130409.72142.FE DOI: 10.1161/01.CIR.000-
  • Curran, M.E., Splawski, I., Timothy, K.W., Vincent, G.M., Green, E.D., Keating, M.T. A molecular basis for cardiac arrhythmia: Herg mutations cause long QT syndrome. Cell 1995(80): 795-803 DOI: 10.1016/0092-8674(95)90358-5
  • Wang, Q., Shen, J., Splawski, I., Atkinson, D., Li, Z., Robinson, J,L, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995(80): 805-811 DOI: 10.1016/0092-8674(95)90359-3
  • Mohler, P.J., Schott, J.J., Gramolini, A.O., Dilly, K., Guatimosim, S., duBell, W.H. et al. Ankyrin-b mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003(421): 634-639 DOI: 10.1038/nature01335
  • Vatta, M., Ackerman, M.J., Ye, B., Makielski, J.C., Ughanze, E.E., Taylor, E.W. et al. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 2006(114): 2104-2112 DOI: 10.1161/CIRCULATIONAHA.106.635268
  • Makita, N., Yagihara, N., Crotti, L., Johnson. C,N, Beckmann, B.M., Roh, M.S. et al. Novel calmodulin mutations associated with congenital arrhythmia susceptibility. Circ. Cardiovasc. Genet. 2014(7): 466-474 DOI: CIRCGENETICS.113.000459
  • Crotti, L., Johnson, C.N., Graf, E., De Ferrari, G.M., Cuneo, BF., Ovadia, M. et al. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation 2013(127):1009-1017 DOI: 10.1161/CIRCULATIONAHA.112.001216
  • Gussak, I., Brugada, P., Brugada, J., Wright, R.S., Kopecky, S.L., Chaitman, B.R. et al. Idiopathic short QT interval: A new clinical syndrome? Cardiology 2000(94): 99-102. DOI: 47299.
  • Gaita, F., Giustetto, C., Bianchi, F., Wolpert, C., Schimpf, R., Riccardi, R. et al. Short QT syndrome: A familial cause of sudden death. Circulation 2003(108): 965-970 DOI: 10.1161/01.CIR.0000085071.28695.C4
  • Mazzanti, A., O’Rourke, S., Ng, K., Miceli, C., Borio, G., Curcio, A. et al. The usual suspects in sudden cardiac death of the young: A focus on inherited arrhythmogenic diseases. Expert Rev. Cardiovasc. Ther. 2014(12):499-519. DOI: 10.1586/14-779072.2014.894884.
  • Kobza, R., Roos, M., Niggli, B., Abacherli, R., Lupi, G.A., Frey, F. et al. Prevalence of long and short QT in a young population of 41,767 predominantly male swiss conscripts. Heart Rhythm 2009(6):652-657 DOI: 10.1016/j.hrthm.2009.01.009
  • Miyamoto, A., Hayashi, H., Yoshino, T., Kawaguchi, T., Taniguchi, A., Itoh, H. et al. Clinical and electrocardiographic characteristics of patients with short QT interval in a large hospital-based population. Heart Rhythm 2012(9):66-74 DOI: 10.1016/j.hrthm.2011.08.016
  • Nierenberg, D.W. Spironolactone and metabolic acidosis. Ann. Intern. Med. 1979(91):321-322 DOI: 10.7326/0003-4819-91-2-321_3
  • Holbrook, M., Malik, M., Shah, R.R., Valentin, J.P. Drug induced shortening of the QT/QTC interval: An emerging safety issue warranting further modelling and evaluation in drug research and development? J. Pharmacol. Toxicol. Methods 2009-(59):21-28 DOI: 10.1016/j.vascn.2008.09.001
  • Giustetto, C., Schimpf, R., Mazzanti, A., Scrocco, C., Maury, P., Anttonen, O. et al. Long-term follow-up of patients with short QT syndrome. J. Am. Coll. Cardiol. 2011(58): 587-595 DOI: 10.1016/j.jacc.2011.03.038
  • Gollob, M.H., Redpath, C.J., Roberts, J.D. The short QT syndrome: Proposed diagnostic criteria. J. Am. Coll. Cardiol. 2011(57): 802-812. 2010.09.048 DOI: 10.1016/j.jacc
  • Brugada, R., Hong, K., Dumaine, R., Cordeiro, J., Gaita, F., Borggrefe, M. et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004(109): 30-35 DOI: 10.1161/01.CIR.0000109482.92774.3A
  • Templin, C., Ghadri, J.R., Rougier, J.S., Baumer, A., Kaplan, V., Albesa, M. et al. Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6). Eur. Heart J. 2011(32): 1077-1088 DOI: 10.1093/eurheartj/ehr076
  • Berne, P., Brugada, J. Brugada syndrome 2012. Circ. J. 2012(76): 1563-1571 DOI: 10.1253/circj.CJ-12-0717
  • Coronel, R., Casini, S., Koopmann, T.T., Wilms-Schopman, F.J., Verkerk, A.O., de Groot, J.R. et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: A combined electrophysiological, genetic, histopathologic, and computational study. Circulation 2005(112): 2769-2777 DOI: 10.1161/CIRCULATIONAHA.105.532614
  • Priori, S.G., Wilde, A.A., Horie, M., Cho, Y., Behr, E.R., Berul, C. et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: Document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013(10): 1932-1963 DOI: 10.1016/j.hrthm.2013.05.014
  • Chen, Q., Kirsch, G.E., Zhang, D., Brugada, R., Brugada, J., Brugada, P. et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998(392):293-296 DOI: 10.1038/32675
  • Brugada, R., Campuzano, O., Sarquella-Brugada, G., Brugada, J., Brugada, P. Brugada syndrome. Methodist Debakey Cardiovasc J. 2014(10): 25-28 DOI: 10.14797/mdcj-10-1-25
  • Hu, D., Barajas-Martinez, H., Pfeiffer, R., Dezi, F., Pfeiffer, J., Buch, T. et al. Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. J. Am. Coll. Cardiol. 2014(64): 66-79 DOI: 10.1016/j.jacc.2014.04.032
  • Cordeiro, J.M., Marieb, M., Pfeiffer, R., Calloe, K., Burashnikov, E., Antzelevitch, C. Accelerated inactivation of the l-type calcium current due to a mutation in CACNB2B underlies Brugada syndrome. J. Mol. Cell Cardiol. 2009(46): 695-703 DOI: 10.1016/j.yjmcc.2009.01.014
  • Burashnikov, E., Pfeiffer, R., Barajas-Martinez, H., Delpon, E., Hu, D., Desai, M. et al. Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm 2010(7): 1872-1882 DOI: 10.1016/j.hrthm.2010.08.026/
  • Kattygnarath, D., Maugenre, S., Neyroud, N., Balse, E., Ichai, C., Denjoy, I. et al. MOG1: A new susceptibility gene for Brugada syndrome. Circ. Cardiovasc. Genet. 2011(4):261-268 DOI: 10.1161/CIRCGENETICS.110.959130
  • Shy, D., Gillet, L., Abriel, H. Cardiac sodium channel NaV1.5 distribution in myocytes via interacting proteins: The multiple pool model. Biochim. Biophys. Acta 2013(1833):886-894 DOI: 10.1016/j.bbamcr.2012.10.026
  • Priori, S.G., Napolitano, C., Tiso, N., Memmi, M, Vignati, G., Bloise, et al. Mutations in the cardiac ryanodine receptor gene (HRYR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001(103):196-200 DOI: 10.1161/01.CIR.103.2.196
  • Postma, A.V., Denjoy, I., Hoorntje, T.M., Lupoglazoff, J.M., Da Costa, A., Sebillon, P. et al. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ. Res. 2002(91):21-26 DOI: 10.1161/01.RES.0000038886.18992.6B
  • Sumitomo, N. Current topics in catecholaminergic polymorphic ventricular tachycardia. J. Arrhythm. 2016(32):344-351 DOI: 10.1016/j.joa.2015.09.008
Еще
Статья